Resmed (RMD) Long-Term Deferred Tax (2010 - 2026)

Resmed has reported Long-Term Deferred Tax for 17 years, with the latest figure at $312.6 million in Q1 2026.

• For the quarter ending Q1 2026, Long-Term Deferred Tax rose 44.19% year-over-year to $312.6 million; the trailing twelve-month figure through Mar 2026 stood at $312.6 million (up 44.19% YoY), and the FY2025 full-year result was $253.1 million, up 24.34% from the prior year.
• Long-Term Deferred Tax for Q1 2026 stood at $312.6 million, up from $285.9 million in the prior quarter.
• The five-year high for Long-Term Deferred Tax was $312.6 million in Q1 2026, with the low at $74.8 million in Q1 2022.
• Historically, Long-Term Deferred Tax has averaged $175.5 million across 5 years, with a median of $162.1 million in 2024.
• Annual changes were most pronounced in 2022 — Long-Term Deferred Tax retreated 0.2% — and 2023, when it surged 81.8%.
• Resmed's Long-Term Deferred Tax stood at $85.8 million in 2022, then jumped by 81.8% to $156.0 million in 2023, then soared by 34.3% to $209.4 million in 2024, then jumped by 36.51% to $285.9 million in 2025, then rose by 9.33% to $312.6 million in 2026.
• The last three Long-Term Deferred Tax figures came in at $312.6 million (Q1 2026), $285.9 million (Q4 2025), and $275.9 million (Q3 2025), per Business Quant data.